Overall rank by patents
#5,284
of 49,997 tracked assignees
USPTO PatentsView assignee record - 65 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Glaukos ranks #5,284 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R5284 · US Corporation #5,284 · 65 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Foxlink Image Technology Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Glaukos · this assignee
43 score
Imprivata · near
43 score
National Christmas… · near
43 score
QM Power · near
43 score
Sionyx · near
43 score
3D Lighting… · lowest
7 score
What this shows Glaukos's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Glaukos Corporation is a focused PatentsView assignee: 13 CPC subclasses with 76.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (12 grants) versus a trough of 2 in 2016. By volume, Glaukos sits between Foxlink Image Technology Co., Ltd. and Himax Display, Inc..
From 2019–2021 to 2022–2024, Glaukos Corporation moved from 25 to 15 grants (0.60x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Foxlink Image Technology Co., Ltd.
65 patents
Galvani Bioelectronics Limited
65 patents
Graco Children's Products, Inc.
65 patents
Gachon University of Industry-Academic Cooperation Foundation
65 patents
Hisense Co., Ltd.
65 patents
Hydac Technology GMBH
65 patents
Headwater Partners II LLC
65 patents
Himax Display, Inc.
65 patents
Glaukos Corporation
65 patents
What this shows Glaukos holds 65 patents at rank #5,285, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,285 in granted patent volume.
Other assignees with the most granted patents in Glaukos's primary technology class.
Two PlainPatent-derived peer sets for Glaukos, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Glaukos ranks #118 of 3,082 assignees by patent count in that subclass.
Nearest assignees by Innovation Score (43 here).
Nearest assignees by average claims per patent (19.4 here).
Glaukos's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 4.6% |
| 2016 | 2 | 3.1% |
| 2017 | 7 | 10.8% |
| 2018 | 4 | 6.2% |
| 2019 | 12 | 18.5% |
| 2020 | 7 | 10.8% |
| 2021 | 6 | 9.2% |
| 2022 | 3 | 4.6% |
| 2023 | 6 | 9.2% |
| 2024 | 6 | 9.2% |
| 2025partial year | 9 | 13.8% |
Top 13 of 13 technology areas
Overall rank by patents
#5,284
of 49,997 tracked assignees
42.9 out of 100
What to do with this data
Glaukos Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.